Grupo Espanol De Leucemia Linfocitica Cronica
- Address
- Calle De Panama 10 1 D
Sponsor Overview
Specializations
Richter’s syndrome
Clinical research activity is centered on Richter’s syndrome, with particular attention to aggressive transformation of chronic lymphocytic leukaemia into diffuse large B-cell lymphoma. The sponsor’s funded trial landscape reflects interest in first-line treatment strategies for newly diagnosed disease and in immunotherapy combined with standard chemotherapy backbones.
- Diffuse large B-cell lymphoma-Richter syndrome
- Chronic lymphocytic leukaemia transformation
- First-line treatment in aggressive B-cell lymphoma
- CD20-directed immunotherapy
The research setting includes multiple collaborating sites in Spain, indicating a coordinated focus on specialised haematology and lymphoma care.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Phase II Evaluation of Mosunetuzumab Combined with CHOP Regimen in Treatment-Naïve Patients with Richter's Syndrome |  Spain | Not Recruiting |
Data & Insights
This sponsor works with 5 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 14 sites across their trial portfolio.
Therapeutic Focus
- 1.Hemic and Lymphatic Diseases1 trial249 other sponsors
Partnered Research Centres
14 centres- Address
- Barranco De La Ballena S N, 35010 Las Palmas de Gran Canaria
- Address
- Calle Villarroel 170, 08036 Barcelona
- Address
- Avenida De San Juan Bosco 15, 50009 Zaragoza
- Address
- Terreno Autovia Mediterraneo A-7 S/n, 29603 Marbella
- Address
- Avenida Del Marques De Los Velez S/n, 30008 Murcia
- Address
- Avenida De Cordoba Sn, 28041 Madrid
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Grupo Espanol De Leucemia Linfocitica Cronica.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.